PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17011047-2	2006	The cannabinoid receptor agonist, HU210 attenuated lipopolysaccharide (LPS)-induced increases in IL-1beta and TNFalpha in rat brain and IL-1beta, TNFalpha, IL-6 and IFNgamma in plasma.	HU 211	34-39	tumor necrosis factor	Rattus norvegicus	110-118	
15728830-8	2005	Cannabinoids (HU-210, WIN55,212-2, and JWH-133) block betaA-induced activation of cultured microglial cells, as judged by mitochondrial activity, cell morphology, and tumor necrosis factor-alpha release; these effects are independent of the antioxidant action of cannabinoid compounds and are also exerted by a CB2-selective agonist.	HU 211	14-20	tumor necrosis factor	Rattus norvegicus	167-194	
14664914-8	2003	Dexanabinol, an N-methyl-D-aspartate antagonist with antioxidant and anti-TNFalpha properties, completely rescued the cells.	HU 211	0-11	tumor necrosis factor	Rattus norvegicus	74-82	
10202976-2	1999	Dexanabinol is a noncompetitive N-methyl-D-aspartate antagonist, with antioxidant and anti-TNFalpha properties.	HU 211	0-11	tumor necrosis factor	Rattus norvegicus	91-99	
10626663-1	2000	Dexanabinol (HU-211) is a synthetic non-psychotropic cannabinoid which suppresses TNF-alpha production in the brain and peripheral blood.	HU 211	0-11	tumor necrosis factor	Rattus norvegicus	82-91	
10626663-1	2000	Dexanabinol (HU-211) is a synthetic non-psychotropic cannabinoid which suppresses TNF-alpha production in the brain and peripheral blood.	HU 211	13-19	tumor necrosis factor	Rattus norvegicus	82-91	
9042110-0	1997	Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.	HU 211	63-74	tumor necrosis factor	Rattus norvegicus	95-104	
9042110-0	1997	Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.	HU 211	76-82	tumor necrosis factor	Rattus norvegicus	95-104	
9042110-6	1997	We report here that HU-211 is a novel inhibitor of TNF-alpha production at a post-transcriptional stage.	HU 211	20-26	tumor necrosis factor	Rattus norvegicus	51-60	
8627042-2	1996	HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist recently demonstrated to inhibit tumor necrosis factor-alpha production under various conditions, improves recovery in some experimental models of brain injury.	HU 211	0-6	tumor necrosis factor	Rattus norvegicus	96-123